These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

582 related articles for article (PubMed ID: 8462229)

  • 1. Clinical pharmacokinetics of angiotensin converting enzyme (ACE) inhibitors in renal failure.
    Hoyer J; Schulte KL; Lenz T
    Clin Pharmacokinet; 1993 Mar; 24(3):230-54. PubMed ID: 8462229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical pharmacokinetics of the newer ACE inhibitors. A review.
    Kelly JG; O'Malley K
    Clin Pharmacokinet; 1990 Sep; 19(3):177-96. PubMed ID: 2203579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Newer ACE inhibitors. A look at the future.
    Salvetti A
    Drugs; 1990 Dec; 40(6):800-28. PubMed ID: 2078997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pharmacokinetics and selective pharmacodynamics of new angiotensin converting enzyme inhibitors: an update.
    Song JC; White CM
    Clin Pharmacokinet; 2002; 41(3):207-24. PubMed ID: 11929321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin converting enzyme inhibitors and moderate hypertension.
    McAreavey D; Robertson JI
    Drugs; 1990 Sep; 40(3):326-45. PubMed ID: 2226219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pharmacokinetics of angiotensin converting enzyme inhibitors in patients with renal impairment.
    Begg EJ; Bailey RR; Lynn KL; Robson RA; Frank GJ; Olson SC
    J Hypertens Suppl; 1989 Sep; 7(5):S29-32. PubMed ID: 2681603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of cilazapril in patients with renal failure.
    Fillastre JP; Moulin B; Godin M; Williams PE; Brown AN; Francis RJ; Pinta P; Manfredi R
    Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):275S-282S. PubMed ID: 2527539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic drug interactions with ACE inhibitors.
    Shionoiri H
    Clin Pharmacokinet; 1993 Jul; 25(1):20-58. PubMed ID: 8354016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative evaluation of ACE inhibitors: which differences are relevant?].
    Fischler MP; Follath F
    Schweiz Med Wochenschr; 1999 Jul; 129(29-30):1053-60. PubMed ID: 10464907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin-converting enzyme inhibitors: a comparative review.
    Raia JJ; Barone JA; Byerly WG; Lacy CR
    DICP; 1990 May; 24(5):506-25. PubMed ID: 2188439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the steady-state pharmacokinetics of fosinopril, lisinopril and enalapril in patients with chronic renal insufficiency.
    Sica DA; Cutler RE; Parmer RJ; Ford NF
    Clin Pharmacokinet; 1991 May; 20(5):420-7. PubMed ID: 1652404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fosinopril. Clinical pharmacokinetics and clinical potential.
    Shionoiri H; Naruse M; Minamisawa K; Ueda S; Himeno H; Hiroto S; Takasaki I
    Clin Pharmacokinet; 1997 Jun; 32(6):460-80. PubMed ID: 9195116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative pharmacokinetics of captopril, enalapril, and quinapril.
    Vertes V; Haynie R
    Am J Cardiol; 1992 Apr; 69(10):8C-16C. PubMed ID: 1546641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic, pharmacokinetic, and therapeutic differences among ACE inhibitors.
    White CM
    Pharmacotherapy; 1998; 18(3):588-99. PubMed ID: 9620109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical pharmacokinetics of vasodilators. Part I.
    Kirsten R; Nelson K; Kirsten D; Heintz B
    Clin Pharmacokinet; 1998 Jun; 34(6):457-82. PubMed ID: 9646008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the pharmacokinetics of fosinoprilat with enalaprilat and lisinopril in patients with congestive heart failure and chronic renal insufficiency.
    Greenbaum R; Zucchelli P; Caspi A; Nouriel H; Paz R; Sclarovsky S; O'Grady P; Yee KF; Liao WC; Mangold B
    Br J Clin Pharmacol; 2000 Jan; 49(1):23-31. PubMed ID: 10606834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overview of the angiotensin-converting-enzyme inhibitors.
    Piepho RW
    Am J Health Syst Pharm; 2000 Oct; 57 Suppl 1():S3-7. PubMed ID: 11030016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical pharmacokinetics of the angiotensin converting enzyme inhibitors. A review.
    Kubo SH; Cody RJ
    Clin Pharmacokinet; 1985; 10(5):377-91. PubMed ID: 2994938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of lisinopril, enalapril and enalaprilat in renal failure: effects of haemodialysis.
    Kelly JG; Doyle GD; Carmody M; Glover DR; Cooper WD
    Br J Clin Pharmacol; 1988 Dec; 26(6):781-6. PubMed ID: 2853960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of temocapril and enalapril in patients with various degrees of renal insufficiency.
    Oguchi H; Miyasaka M; Koiwai T; Tokunaga S; Hora K; Sato K; Yoshie T; Shioya H; Furuta S
    Clin Pharmacokinet; 1993 May; 24(5):421-7. PubMed ID: 8504625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.